East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Delivered and Deliverables The Role of.

Slides:



Advertisements
Similar presentations
DEVELOPING THE PRIMARY CARE WORKFORCE Helen Broadbent Director of Modernisation and OD Bradford South & West PCT.
Advertisements

The New Landscape - Transforming Commissioning. Agenda The likely impact of the White Paper on the commissioning landscape The NHS London Commissioning.
East of England East Midlands London North East North West South East Coast South Central South West West Midlands Yorkshire & the Humber NHS Integrated.
Achieving a Digital Integrated Care Record Lois Lere Head of Strategic Systems and Technology (South) Health Insights May 2014.
West Midlands Academic Health Science Network
West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.
West Midlands Academic Health Science Network
The Patient Safety Challenge in the UK Dr Kevin Cleary Medical Director National Patient Safety Agency.
Procurement and Distribution Interest Group and the National Homecare Medicines Committee Jointly presents: Medicines & Homecare Symposium Thursday the.
Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.
The NHS Reforms – a Policy Analyst’s View
National Picture on Homecare Services Mark Hackett CEO Southampton University Hospitals NHS Trust.
Towards Active Engagement
10/05/ PDIG Award 2008/9: Purchasing for Safety – Injectable Medicines Dr Clare Crowley Lead Medicines Safety Pharmacist Oxford Radcliffe Hospitals.
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
North West Coast Patient Safety Collaborative Presented by: Aly Hulme Associate Director.
Pharmacy & National Procurement Christine Gilmour Chief Pharmacist NHS Lanarkshire.
Guild of Healthcare Pharmacists PDIG – Thursday 12 November 3 rd Party Partnerships and Hospital Pharmacy Services Tom Gray Chief Pharmacist, Royal Derby.
Health Education NCEL (North Central and East London) Health Education NWL (North West London) Health Education SL (South London) The power of collaboration.
Chairman, Pharmaceutical Market Support Group
New Procurement & Delivery Arrangements for the Schools’ Estate Presentation to Strategic Advisory Group 18 April 2005.
National Standards for Safer Better Healthcare
Commissioning Intentions for 2015/16 Paul Sinden, Director of Commissioning.
Proposed NWL LETB Governance Care Pathway 1 Care Pathway 2 Care Pathway 3 NWL LETB Board Stakeholder Advisory Group Professional Groups Health Education.
Buyers Taking an Active Role in Patient Safety Patrick Gallagher, CPhT Pharmacy Buyer Marian Medical Center.
Pathology Modernisation: The Carter Report and implications
London, Eastern and South East Specialist Pharmacy Services Clinical Pharmacy Clinical Governance & Technical Services Community Care Education & Training.
AHSN Stakeholder Event Centre for Life, Newcastle Tuesday 23 rd June 2015 Patient Safety Collaboratives: the North East approach Tony Roberts, Interim.
‘No Needless Medication Errors’
‘No Needless Medication Errors’ Gillian Honeywell, Chief Pharmacist Fiona Eccleston, Project Manager NHS Isle of Wight South Central.
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Reducing Medication Errors findings of the National Clinical Governance Protected Time Project Paul MooreClinical Governance Manager.
Should we receive professional procurement training? Matt Condon Pharmacy Procurement Manager PDIG Autumn Symposium Thursday, 11 th November 2010.
FUTURE COMMISSIONING North Kesteven – Provider Forum Thursday 25 th September 2008 Ken Fairbairn Head of Commissioning Provider Relationships & Contracts.
Definition:  medication that have a higher likelihood of causing injury if they are misused. Errors with these medications are not necessarily more frequent-
Wessex Public Health Network – Your Questions
Having your say within the new NHS health structures.
PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007
Ms Rebecca Brown Deputy Director General, Department of Health
The Role of the Research Office Joint Research & Enterprise Office (JREO) St George’s University of London and St George’s University Hospitals NHS Foundation.
Ramside Hall, 14th May 2015 The Academic Health Science Network for North East and North Cumbria Patient Safety Collaborative An introduction to the PSC.
AFAMS EO Storage of ISMP High Alert Medications (Dari) 01/09/2013.
Outsourcing Pharmacy Services Mike Cross Managing Director Hambleton Medical Ltd.
EHealth Strategy Scotland Anna Daley Professional Officer CPHVA.
Older People’s Services The Single Assessment Process.
Letting contracts for successful delivery by the voluntary and community sector Voluntary Sector Excellence Project, Estonia Richard Gutch, Chief Executive,
A Hospital without a Pharmacy - building a first class pharmacy service Anne Cope Associate Director of Pharmacy University Hospital Birmingham NHS Foundation.
Tony Chambers Chief Executive Tony Chambers Chief Executive Debbie O’Neill Director of Finance Debbie O’Neill Director of Finance Departmental/ functional.
The Primary Care Home Dr Sanjiv Ahluwalia NAPC Executive.
NHS Education & Training Operating Model from April 2013 Liberating the NHS: Developing the Healthcare Workforce From Design to Delivery.
North Somerset Clinical Commissioning Group ‘You said…We did’ Dr Mary Backhouse Chief Clinical Officer.
Hertfordshire Partnership NHS Foundation Trust FOUNDATION TRUST ITEM 3 Herts Partnership Foundation Trust Presentation.
Opportunities in 2012 and Beyond The Way Forward Stuart Semple Director of Pharmacy and Medicines Management Barts Health NHS Trust.
Managed Care Career Path for Student Pharmacists Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2015.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Clinical Pharmaceutical Science
NHS Five Year Forward View and the 10 Point Plan – Building the Workforce – the New Deal for General Practice Lisa Soultana Director of Business Development.
Buying and Selling Specials in 2012 What the NHS customer wants How the contracting process helps them to get it Jane Page Principal Pharmacist Medicines.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast The Challenge: Tendering for Unlicensed.
Cross Economy Case Study Cardiology Pathway Redesign Over the last few years England has been experiencing increasing demands on its urgent and emergency.
How Innovating for Health Could Benefit Patients and our Trusts’ Wealth What Could We Do Differently? Suzanne Goodband
II Volga specialized forum "Medicine. Pharmacy"
Nurse Supply and Demand Programme
General Practice Forward View (GPFV)
Workforce Priorities in the Nottinghamshire STP
Our Vision / A look forward
The ‘New’ NHS – The Challenges for Children’s Service
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Presentation transcript:

East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Delivered and Deliverables The Role of the National Advisory Board Tim Root Specialist Pharmacist Clinical Governance & Technical Services

East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast “Ask not what the NAB has done for you but, rather, ask what you can do for the NAB”

East & South East England Specialist Pharmacy Services Background  Modernisation Board & Programme  £46m capital investment  NPSA Medication Safety Package  PaSA Purchasing for Safety initiative  National Advisory Board Epidurals, potassiumCritical Care Drugs IV Guide monographsDose banded cytotoxicsB.A.D dermatologicals Work Plan

East & South East England Specialist Pharmacy Services NAB membership Director of Specialised Commissioning Medicines Procurement NPSAMHRASHAPaSA/CMU Radio Pharmacy NHS Medicines Manufacturing Devolved Administrations

East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Oversight and coordination… Configuration of an integrated national service Collaboration to deliver priorities for manufacture, preparation & use of UMPs Collaboration to deliver priorities for manufacture, preparation & use of UMPs Raising awareness & advising on manufacture and use of UMPs Raising awareness & advising on manufacture and use of UMPs NAB functions

East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NAB Terms of Reference Capital Investment, revenue & Income management Capacity & capability Manpower & workforce BP monographs Inventory rationalisation & management

East & South East England Specialist Pharmacy Services The NAB work programme 1.Rationalisation of cytotoxic chemo dose banding products 2.Identification of priorities, development and sourcing of safer “high-risk” injectable intensive care medicines 3.Development & publication of monographs for priority products 4.New product specifications 5.National IV guide monographs 6.BP monographs

East & South East England Specialist Pharmacy Services The NAB work programme 4.Standardisation of adult, paediatric & obstetric epidural infusions for acute pain 5.Promoting awareness of and compliance with the BAD-preferred list of skin products

East & South East England Specialist Pharmacy Services Some (National) priority products Noradrenaline 4,8,16mg in 50ml; 8,16,32mg in 100ml Insulin: 50 units in 50ml Phenylephrine 1mg in 10ml Heparin 1000unit in 1ml Amiodarone 300mg in 50ml; 900mg in 500ml

East & South East England Specialist Pharmacy Services The importance of being rational Increases familiarity, reduces risks of error by all Reduces user training needs More users=less extemps = cost-effective manufacture of Specials = more sales = more chance of a licensed product even pan-NHS-only products are no longer commercially very attractive But….. XMost doctors and nurses don’t get this!

East & South East England Specialist Pharmacy Services Potassium acid Phosphate 9mmol in 500ml Sodium chloride Injection 0.9% Potassium acid Phosphate 10mmol in 250ml Water for Injections “The difference is clinically significant?”: discuss

East & South East England Specialist Pharmacy Services NAB needs you

East & South East England Specialist Pharmacy Services Where do NHS Medicines preparative services fit in? …..as a key part of a mixed economy

East & South East England Specialist Pharmacy Services NHS role in medicines manufacturing NHS is less good at high-use products & logistics NHS capacity must be retained & protected for Specific product types NHS capacity must be retained & protected for Specific product types Independent sector is well suited to high use, long shelf-life etc Independent sector is well suited to high use, long shelf-life etc

East & South East England Specialist Pharmacy Services Opportunities Hubs & NHS Commercial Medicines Unit (= PaSA) Market management Quality management New technology Do we have the right tools? Can we afford and exploit them? Primary Care Unmet need IMPs Unmet need Dose banded cytos Increase service capacity Logistics partnerships One-stop shop; cross docking Licensed PN bags Could meet 40-80% of total demand? NHS Medicines manufacturing Inc

East & South East England Specialist Pharmacy Services Threats, risks, opportunities Foundation Trusts and the financial climate Are pharmacy technical services core NHS business? Foundation Trusts and the financial climate Are pharmacy technical services core NHS business? Recruitment & Staffing Competition Tendering Regulatory burden Cost

East & South East England Specialist Pharmacy Services Risk or opportunity? QA services Stability data formulation development Stability data formulation development Centralised labs Validation & commissioning of equipment, facilities Validation & commissioning of equipment, facilities Pharmacovigilance Label design

East & South East England Specialist Pharmacy Services NHS collaborative working Shared Services Marketing & Communications Tendering/contracting Patient Information Label design Pharmacovigilance Pro-File/Formulary

East & South East England Specialist Pharmacy Services The future 1. Core BusinessNHS must want it 2. NHS Medicines Manufacturing Inc New Business Model 3. Rationalisation of ProductsProducts: Local & national product lists (formularies) 3. Rationalisation of NHS UnitsFewer, bigger licensed units batch manufacturing Local (aseptic) units making only what no-one else can 4.Mixed economy Work with hubs & independent Pharma to manage the market

East & South East England Specialist Pharmacy Services So what…? …. do we do next

East & South East England Specialist Pharmacy Services Mix with the right people! Talk & listen Share information, ideas Progress…..and business opportunities Be patient! Be transparent about potential costs & prices in advance Don’t make assumptions Beware non-pharmacists bearing ideas!

East & South East England Specialist Pharmacy Services We have to work at it…..

East & South East England Specialist Pharmacy Services The National IV Guide? For more information… Questions%20and%20answers%20May% pdf

East & South East England Specialist Pharmacy Services Thanks to….. Fellow NAB members, Kevan Wind, Clare Crowley, Susan Keeling, Mark Borthwick…..to name but a few